ZA95956B - The use of anti-tnf antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6 - Google Patents

The use of anti-tnf antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6

Info

Publication number
ZA95956B
ZA95956B ZA95956A ZA95956A ZA95956B ZA 95956 B ZA95956 B ZA 95956B ZA 95956 A ZA95956 A ZA 95956A ZA 95956 A ZA95956 A ZA 95956A ZA 95956 B ZA95956 B ZA 95956B
Authority
ZA
South Africa
Prior art keywords
interleukin
disorders
drugs
treatment
serum level
Prior art date
Application number
ZA95956A
Inventor
Roswitha Stenzel
Martin Kaul
Lothar Daum
Joachim Kempeni
Christa Raab
Sibylle Schaefer
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of ZA95956B publication Critical patent/ZA95956B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA95956A 1994-02-07 1995-02-07 The use of anti-tnf antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6 ZA95956B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4403669 1994-02-07

Publications (1)

Publication Number Publication Date
ZA95956B true ZA95956B (en) 1995-10-11

Family

ID=6509608

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA95956A ZA95956B (en) 1994-02-07 1995-02-07 The use of anti-tnf antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6

Country Status (5)

Country Link
KR (1) KR100414505B1 (en)
DE (2) DE4409513C1 (en)
RU (1) RU2197990C2 (en)
UA (1) UA46731C2 (en)
ZA (1) ZA95956B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3631229A1 (en) * 1986-09-13 1988-03-24 Basf Ag MONOCLONAL ANTIBODIES AGAINST HUMAN TUMORNESCROSE FACTOR (TNF) AND THEIR USE
AU648777B2 (en) * 1989-12-04 1994-05-05 Schering Corporation Method of treating septic shock

Also Published As

Publication number Publication date
DE59510625D1 (en) 2003-05-08
KR100414505B1 (en) 2004-03-30
DE4409513C1 (en) 1995-10-19
RU2197990C2 (en) 2003-02-10
UA46731C2 (en) 2002-06-17

Similar Documents

Publication Publication Date Title
AU1520195A (en) Use of anti-tnf antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels
US5443960B1 (en) Method for the diagnosis of blood coagulation disorders
EP0088900A3 (en) Device for purifying the blood from metabolism substances
DE68909691D1 (en) Multi-layer body for the delivery of fragrances.
FR2714848B1 (en) Microcapsules and methods for their preparation.
EP0701569A4 (en) Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
ITMI941928A0 (en) PROCEDURE FOR THE MANUFACTURE OF PERSAL PARTICLES
EP0651639A4 (en) Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders.
DE3380125D1 (en) Assay for the free portion of substances in biological fluids
DE3862585D1 (en) THERAPY DEVICE FOR REFRIGERATION APPLICATION.
AU5507098A (en) Enhancement of dna immunization through the use of cytokines
EP0324922A3 (en) An arrangement for the diffusion of substances between two fluids
IL70746A0 (en) Specific cea-family antigens,antibodies specific thereto and methods for the use thereof
DK132884A (en) PROCEDURE FOR PROVIDING RELATIONSHIP WITH Kidney or Urinary Disorders through the Skin
HUP9602570A2 (en) Process for producing immunoglobulines from fractions produced with fractioning human blood-plasma
DE59500727D1 (en) Device for the production of infusion drinks
DZ2012A1 (en) Benzamides for the treatment of neurological degenerations.
GB2216412B (en) Interleukin-6 molecule for the treatment of bone-related diseases
FR2612736B1 (en) URBAN FURNITURE FOR THE COMFORT OF PETS
EP0981357A4 (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
HU9500322D0 (en) Process for separating estrogenes from the urine of mares with foal
ZA95956B (en) The use of anti-tnf antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6
DE3369386D1 (en) Assay for the free portion of substances in biological fluids
SI0804236T1 (en) Use of anti-tnf antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels
ZA903625B (en) Imidazodiazepines for the treatment of neurological symptoms